2 hours ago
Hims & Hers (HIMS) Stock Surges 7% on Eli Lilly Weight Loss Drug Partnership Expansion
Hims & Hers (HIMS) stock surged 7% after expanding its Eli Lilly partnership to include Zepbound and other GLP-1 weight loss medications on its platform.
The post Hims & Hers (HIMS) Stock Surges 7% on Eli Lilly Weight Loss Drug Partnership Expansion appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
United Rentals (URI) Stock Soars 20% Following Robust Q1 Results and Upgraded Fo...
- 1 hour ago
Circle Internet Group (CRCL) Stock Surges 9.7% on Freedom Capital Analyst Rating...
- 2 hours ago
Amazon (AMZN) Stock Reaches Record Peak Fueled by Cloud Computing Growth and Ana...
- 2 hours ago
Conagra Brands (CAG) Stock: Insiders Buy Over $600K Amid Sharp Decline
- 2 hours ago
Warner Bros Discovery (WBD) Stock: Paramount’s $81B Acquisition Gets Shareholder...
